Yumen Bionics makes dreams come true
Together, dreams become even more beautiful
At Yumen Bionics, we want to make dreams come true. We build exoskeletons to support the arm movements of patients with Duchenne disease, so that they can use these arms again. Sometimes for what they prefer to do most, but always to ‘just’ move them again. The euphoria of a patient experiencing our exoskeletons’ working is immense.
We design our exoskeletons extremely flexibly. This way, we can easily adapt the construction to the individual, their wishes, and the latest insights. For precisely that reason, about sixty (!) components have been manufactured using the 3D printing technique. If we come up with a new part today, we will have it tomorrow.
For that 3D printing process, we have engaged in a splendid collaboration with one of the forerunners in the field: Parts On Demand. A party that, like us, looks at what yields the best result. A party that, just like us, thinks along with the user. A party that, just like us, wants to be able to respond quickly to an evolving design.
Just like us, they embrace the notion that the focus should lie solely on the end result. That is why give us their full support, no strings attached, on the development of our prototypes. In thinking along, in the use of production space, in delivering the components for the prototypes. So that we can achieve our goal. Because together, you get things done more quickly. Together we make dreams come true.
Why is our name so ‘complicated’ in its spelling? ‘Yume’ is Japanese for ‘dream’. And we set out to make dreams come true. Therefore: Yumen Bionics.
Digital Tools for Rare Disease (DT4RD)
Aparito are proud to announce the launch of the three year Digital Tools for Rare Disease project (DT4RD), a product of the Rare Disease Research call placed by the European Joint Programme on Rare Diseases in partnership with Fondation Maladies Rares to develop non-invasive tools for measuring mobility in rare disease patients.
The DT4RD project brings together a multinational consortium consisting of Aparito, Paris Institut de Myologie (Institute of Myology), The John Walton Muscular Dystrophy Research Centre at Newcastle University, Yumen Bionics, Metabolic Support UK, along with biotechnology and pharmaceutical industry partners, CSL Behring and Chiesi Pharmaceuticals who will both serve as the sponsors of the project.
In order to meet the objective set by the call the project consortium will develop a digital platform capable of assessing upper limb function remotely and continuously, capturing the point between being ambulant and non-ambulant, a pivotal juncture in the progression of rare diseases which is often not accounted for with the use of conventional clinical methodology and tools.
Over the course of three years, Aparito’s Atom5TM software platform will be integrated with state-of-the-art wearable sensors developed by Yumen Bionics to create an integrated platform which will amass data covering physiological and psychosocial parameters and will be tested across two clinical centres in Paris and Newcastle, UK, respectively.
Application for ALS patients
In collaboration with Stichting ALS Nederland, a feasibility study is conducted to identify and increase the added value of the Yumen technologies for patients with ALS.
Rehabilitation device for stroke
FEXO supports a modular approach in order to address patients’ rehabilitation needs in a personalized and progressive manner. This approach enables the use of complementary techniques that show beneficial effects on upper extremity rehabilitation.